Simplify Logo

Full-Time

Sr. Manager

Visual Inspection, Labeling and Packaging Operations

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Healthcare
Biotechnology

Senior, Expert

Norwood, MA, USA

70% in-office structure required.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Management
Requirements
  • Bachelor of Science degree in Engineering, Pharmaceutical Sciences, or a related technology discipline.
  • A minimum of 8 years of experience in drug product inspection, labeling, and packaging, with at least 2 years in a leadership role.
  • Experience working with semi-automated inspection equipment.
  • Experience working with semi-automated labeling and packaging equipment.
  • Proficiency with clinical and commercial labeling requirements including med IDs and serialization.
  • Experience developing Knapp Test Kits and implementing an operator qualification strategy in support of visual inspection.
  • In-depth knowledge of cGMP regulations, pharmaceutical processing, and cleanroom operations.
  • Strong leadership skills with the ability to develop and motivate a diverse team.
  • Excellent project management, organizational, and communication skills.
  • Demonstrated ability to work cross-functionally and manage complex projects with multiple stakeholders, with the ability to convey complex information in an understandable manner to various stakeholders.
  • Experience with budget management and cost optimization in a manufacturing environment.
  • Problem-solving mindset with a commitment to quality and safety.
Responsibilities
  • Develop and execute Operational readiness strategies to ensure the successful launch and ongoing production of drug products,
  • Establish robust operational readiness plans to transition from the construction phase to full-scale production, ensuring all systems and processes are in place for cGMP compliance,
  • Oversee the hiring, training, and development of a high-performing operations team capable of executing visual inspection, labeling, and packaging across multiple production lines,
  • Collaborate with cross-functional teams working in a highly matrixed environment to drive decisions and influence outcomes to enable Moderna’s clinical pipeline,
  • Drive continuous improvement initiatives to enhance operational efficiency, reduce costs, and improve product quality,
  • Develop and manage the operational budget, including capital expenditure planning and cost control measures,
  • Lead risk management activities to identify potential operational issues and implement mitigation strategies,
  • Ensure adherence to all environmental, health, and safety guidelines, promoting a culture of safety within the operations team,
  • Establish key performance indicators (KPIs) to measure and report on operational performance, making data-driven decisions to optimize processes,
  • Foster a culture of innovation and collaboration, encouraging team members to contribute ideas for process improvements and operational excellence,
  • Serve as the primary point of contact for operations during regulatory inspections and audits.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

8%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.